Ongoing tragedy of rabies

Cell-culture rabies vaccines for humans have lagged far behind those for animals in the developing world. Low-cost continuous cell line (CCL) rabies vaccines should be equally acceptable for human use in both the developed and the developing world.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1993-10, Vol.342 (8879), p.1067-1068
Main Author: Petricciani, JohnC
Format: Article
Language:English
Subjects:
Animals
Developing Countries
Humans
LDCs
Rabies
Rabies - immunology
Rabies Vaccines - economics
Vaccines
World Health Organization
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell-culture rabies vaccines for humans have lagged far behind those for animals in the developing world. Low-cost continuous cell line (CCL) rabies vaccines should be equally acceptable for human use in both the developed and the developing world.
ISSN:0140-6736
1474-547X
DOI:10.1016/0140-6736(93)92058-2